DK0885014T3 - Farmaceutiske præparater indeholdende bufrede orthoesterpolymerer - Google Patents

Farmaceutiske præparater indeholdende bufrede orthoesterpolymerer

Info

Publication number
DK0885014T3
DK0885014T3 DK97906128T DK97906128T DK0885014T3 DK 0885014 T3 DK0885014 T3 DK 0885014T3 DK 97906128 T DK97906128 T DK 97906128T DK 97906128 T DK97906128 T DK 97906128T DK 0885014 T3 DK0885014 T3 DK 0885014T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
containing buffered
acid
orthoester
Prior art date
Application number
DK97906128T
Other languages
Danish (da)
English (en)
Inventor
Robert Gurny
Monia Zignani
Cyrus Tabatabay
Original Assignee
Robert Gurny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Gurny filed Critical Robert Gurny
Application granted granted Critical
Publication of DK0885014T3 publication Critical patent/DK0885014T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
DK97906128T 1996-03-05 1997-02-26 Farmaceutiske præparater indeholdende bufrede orthoesterpolymerer DK0885014T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96103391 1996-03-05
PCT/EP1997/000906 WO1997032606A1 (en) 1996-03-05 1997-02-26 Pharmaceutical compositions containing buffered ortho ester polymers

Publications (1)

Publication Number Publication Date
DK0885014T3 true DK0885014T3 (da) 2003-02-24

Family

ID=8222532

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97906128T DK0885014T3 (da) 1996-03-05 1997-02-26 Farmaceutiske præparater indeholdende bufrede orthoesterpolymerer

Country Status (11)

Country Link
US (1) US6440460B1 (de)
EP (1) EP0885014B1 (de)
JP (1) JP4225570B2 (de)
KR (1) KR100441821B1 (de)
AT (1) ATE226450T1 (de)
AU (1) AU722303C (de)
DE (1) DE69716586T2 (de)
DK (1) DK0885014T3 (de)
ES (1) ES2185911T3 (de)
PT (1) PT885014E (de)
WO (1) WO1997032606A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099438A1 (en) * 1998-04-15 2002-07-25 Furst Joseph G. Irradiated stent coating
US20030040790A1 (en) 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US7967855B2 (en) 1998-07-27 2011-06-28 Icon Interventional Systems, Inc. Coated medical device
US8070796B2 (en) 1998-07-27 2011-12-06 Icon Interventional Systems, Inc. Thrombosis inhibiting graft
US7168489B2 (en) * 2001-06-11 2007-01-30 Halliburton Energy Services, Inc. Orthoester compositions and methods for reducing the viscosified treatment fluids
US8016881B2 (en) 2002-07-31 2011-09-13 Icon Interventional Systems, Inc. Sutures and surgical staples for anastamoses, wound closures, and surgical closures
AU2003270555B2 (en) 2002-09-09 2009-01-29 Nektar Therapeutics Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
US7497278B2 (en) 2003-08-14 2009-03-03 Halliburton Energy Services, Inc. Methods of degrading filter cakes in a subterranean formation
US7691381B2 (en) 2004-04-15 2010-04-06 Allergan, Inc. Stabilized biodegradable neurotoxin implants
AU2006221046B2 (en) 2005-03-03 2012-02-02 Icon Medical Corp. Improved metal alloys for medical device
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US20060200048A1 (en) * 2005-03-03 2006-09-07 Icon Medical Corp. Removable sheath for device protection
WO2006110197A2 (en) 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
TWI409081B (zh) * 2006-11-09 2013-09-21 Alcon Res Ltd 用於藥物輸送之水不溶性聚合物基質
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
BR112016030273A2 (pt) 2014-06-24 2017-08-22 Icon Medical Corp Dispositivo médico e método para formar o referido dispositivo
WO2017151548A1 (en) 2016-03-04 2017-09-08 Mirus Llc Stent device for spinal fusion
HUE066356T2 (hu) 2017-08-24 2024-07-28 Novo Nordisk As GLP-1 készítmények és alkalmazásaik
PE20221575A1 (es) 2020-02-18 2022-10-06 Novo Nordisk As Formulaciones farmaceuticas

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4010196A (en) * 1975-06-25 1977-03-01 American Home Products Corporation Linear polyester salts
US4268643A (en) * 1979-10-25 1981-05-19 Societa Italiana Resine S.I.R. S.P.A. Process for improving the stability of acetal polymers
EP0052916B1 (de) * 1980-11-10 1985-01-02 Alza Corporation Erodierbares Polymer, das eine Verbindung enthält, die die Erosionsrate beeinflusst
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
DE3642662A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Parenterale depotzubereitungen von regulatorischen peptiden enthaltend calciumacetat-glycerin-addukt, verfahren zu ihrer herstellung sowie die verwendung des addukts
JPH05502465A (ja) 1989-08-28 1993-04-28 ファーマスーティカル　デリバリー　システムズ 治療薬剤の制御放出のために有用な生体内で分解し得るポリマー
US5030457A (en) 1989-08-28 1991-07-09 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
WO1993000383A1 (en) 1991-06-20 1993-01-07 Pharmaceutical Delivery Systems, Inc. Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents

Also Published As

Publication number Publication date
DE69716586D1 (de) 2002-11-28
EP0885014A1 (de) 1998-12-23
DE69716586T2 (de) 2003-07-17
ATE226450T1 (de) 2002-11-15
KR19990087477A (ko) 1999-12-27
KR100441821B1 (ko) 2004-10-15
AU2093497A (en) 1997-09-22
JP2000506148A (ja) 2000-05-23
PT885014E (pt) 2003-02-28
EP0885014B1 (de) 2002-10-23
JP4225570B2 (ja) 2009-02-18
AU722303B2 (en) 2000-07-27
WO1997032606A1 (en) 1997-09-12
ES2185911T3 (es) 2003-05-01
US6440460B1 (en) 2002-08-27
AU722303C (en) 2001-12-06

Similar Documents

Publication Publication Date Title
PT885014E (pt) Composicoes farmaceuticas contendo polimeros orto ester tamponados
DK0874642T3 (da) Lægemiddelformuleringer med forhalet frigørelse
WO1999007351A3 (en) Indole derivatives and their use as mcp-1 antagonists
IL143063A0 (en) Cross-linked hyaluronic acids and medical uses thereof
ATE288270T1 (de) Mikroverkapselte 1,2-benzazole
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
NO20002547D0 (no) Poly(vinylamin)-baserte superabsorberende geler og fremgangsmÕte for fremstilling derav
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
WO2007000778A3 (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
HRP20060275A2 (en) 6-0-supstituted ketolides having antibacterial activity
AR021934A1 (es) Composicion de administracion oral con liberacion controlada de al menos un analgesico
MY129437A (en) Drug formulation having controlled release of active compound
IS4996A (is) Lyfjafræðilegar örkúlur með valprósýru til inngjafar um munn
AU2697100A (en) Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
DE69705967D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
AU1998995A (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
HU9700661D0 (en) Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
SE9902742D0 (sv) New pharmaceutical formultion
CA2243988A1 (en) Pharmaceutical compositions containing buffered ortho ester polymers
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
EA200601283A1 (ru) Фармацевтическая композиция с контролируемым высвобождением, содержащая нерастворимый в кислотах полимер и биоадгезивный полимер